The largest database of trusted experimental protocols

Ventana autostainer model discover xt

Manufactured by Roche

The Ventana autostainer model Discover XT is a laboratory instrument used for the automated staining of tissue samples. It is designed to perform immunohistochemistry (IHC) and in situ hybridization (ISH) assays. The core function of the Discover XT is to automate the staining process, allowing for consistent and reproducible results.

Automatically generated - may contain errors

9 protocols using ventana autostainer model discover xt

1

Immunohistochemical Analysis of Xenograft Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining of xenograft tumors was done on formalin-fixed and paraffin embedded 4-μm sections using the Ventana autostainer model Discover XT (Ventana Medical System, Tucson, AZ) with an enzyme-labeled biotin streptavidin system and solvent-resistant 3,3`-diaminobenzidine Map kit. Slides were pretreated with tris borate EDTA buffer (pH 7.8, Roche) for 48 minutes. The following antibodies were used: Ki-67 (mouse monoclonal antibody, DAKO, Denmark), and cleaved caspase-3 (rabbit polyclonal antibody, Cell Signaling). Specificity of staining was controlled by including an unspecific control antibody (DAKO). Slides were counterstained with hematoxylin (Roche). Expression was evaluated manually. Number of Ki-67/cleaved caspase-expressing cells was determined by counting the number of positive cells. The numbers stated in the graphs are means of 10 visual fields at a magnification of 200-fold.
+ Open protocol
+ Expand
2

Immunohistochemical Evaluation of IL-33 in Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical stains were conducted at the Vancouver Prostate Centre using a Ventana autostainer model Discover XT (Ventana Medical System) with enzyme labeled biotin streptavidin system and solvent resistant DAB Map kit using 1/50 concentration of rabbit polyclonal IL-33 antibody (HPA024426; Sigma-Aldrich). Staining was performed on 342 prostate cancer specimens obtained from the Vancouver Prostate Centre. The H&E stained slides were reviewed and the desired areas were marked on them and their correspondent paraffin blocks. Five tissue microarrays (TMAs) were manually constructed (Beecher Instruments) by punching duplicate cores of 1mm for each sample. Stained slides were digitalized with the SL801 autoloader and Leica SCN400 scanning system (Leica Microsystems) at magnification equivalent to ×20. Representative cores (clearly positive, clearly negative and mixed positive/negative) were manually identified by an experienced pathologist (L Fazli) and a four-point scale was assigned as follows: 0 represents no staining in any tumour cells, 1 represents a faint or focal, or questionably present stain, 2 and 3 represents a stain of convincing intensity in a majority of cells. For comparisons, a score of 0 or 1 was considered low IL-33 expression.
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Xenograft Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC was carried out for a total of 19 xenograft tumors from LNCaP cells. The H & E slides were reviewed and the desired areas were marked on them and their correspondent paraffin blocks. TMA was manually constructed (Beecher Instruments, MD, USA) by punching multiple cores of 1 mm for each sample. All the specimen were from xenograft tumors.
Immunohistochemical staining was conducted by Ventana autostainer model Discover XT (Ventana Medical System, Tuscan, Arizona) with enzyme labeled biotin streptavidin system and solvent resistant Red Map kit by using 1:500 of ki67 rabbit polyclonal antibody (Thermoscientific), 1:2,000 concentrations of Filamin mouse monoclonal antibody (abcam), 1:50 of GDF15 Rabbit polyclonal antibody (Abcam) and 1:200 of Caveolin-1 rabbit polyclonal antibody (Cell Signaling).
+ Open protocol
+ Expand
4

Immunohistochemistry Analysis of Cleaved Caspase-3

Check if the same lab product or an alternative is used in the 5 most similar protocols
Xenograft tumor tissues were fixed in 4% paraformaldehyde and performed immunohistochemistry on 5-μm-thick paraffin sections after heat-induced antigen retrieval. IHC was carried out by incubating the primary antibody for cleaved Caspase-3 (Cell Signaling Technology, 1:400) for 30 min at room temperature or mouse pre-immune serum as a control in a fully automated Ventana Autostainer model Discover XT ™ (Ventana Medical System, Tuscan, AZ) using Universal DAB Detcction Kit (Ventana Medical Systems). After counterstaining with haematoxylin, slides were mounted.
+ Open protocol
+ Expand
5

Hypoxic Microenvironment in Pancreatic Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hypoxic microenvironment status, represented by CA-9, was compared between UFS and NAT groups to evaluate the alterations in physiological tumor conditions after NAT in pancreatic cancer.
Immunohistochemistry was performed on 10% formalin neutral buffer solution-fixed, paraffin-embedded tissue sections by Ventana autostainer model Discover XT (Ventana Medical System. A polyclonal goat antibody against human CA-9 antibody (1:300, sc-365900; Santa Cruz Biotechnology, Inc.) was used. In brief, tissue sections were incubated in citrate buffer for 4 min at 72°C to retrieve antigenicity, followed by incubation with the primary antibody. The bound primary antibody was incubated with the anti-goat secondary antibody at 37°C for 8 min and visualized using ultraView Universal DAB Detection Kit (760–500; Roche Diagnostics). The CA-9 sections were scanned using the NanoZoomer 2.0 system (Fig. 1F). The tumor regions without necrosis were encircled to evaluate the hypoxic tumor microenvironment status (Fig. 1G) and quantified using morphometric analysis from a color-detecting algorithm. CA-9 positivity was calculated as the percentage of CA-9-positive pixels out of the entire pixel count using morphometric analysis with the positive pixel count algorithm (Aperio ImageScope, version 12.4; Leica Biosystems) (Fig. 1H) (17 ).
+ Open protocol
+ Expand
6

Immunohistochemical Evaluation of Prostate Tumor Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two serial sections of two tissue microarrays containing human prostate tumor tissues were subjected to Ventana autostainer model Discover XT ™ (Ventana Medical System, Tuscan, AZ). The primary antibodies were anti-DAB2IP [23 (link), 24 (link)]and anti-Skp2 (2C8D9) from Zymed, San Francisco, CA. Two pathologists assessed and scored the immunostaining independently and reached a final consensus for any inconsistent scoring. Briefly, values on a four-point scale were assigned to each specimen. The intensity score was assigned, which represented the average intensity of positive cells (0, none; 1, weak or questionably present stain; 2, intermediate intensity in a minority of cells; and 3, strong intensity in a majority of cells). High expression was defined as score higher than average, and low expression was defined as score lower than average.
+ Open protocol
+ Expand
7

Ventana-based VDR Immunohistochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry (IHC) staining was conducted by Ventana autostainer model Discover XT (Ventana Medical System) with enzyme-labeled biotin streptavidin system and solvent-resistant DAB Map kit by using rabbit polyclonal VDR (H-81; sc-9164) antibody from Santa Cruz Biotechnology, Inc.
+ Open protocol
+ Expand
8

Immunohistochemical Analysis of Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study was approved by the Regional Ethics Committee, REK Sør-Øst (S-07443a), and material from still living patients was included after their written consent. The prostate tissue microarrays (TMAs) for Fig1 were previously described (Klokk et al, 2007 (link); Wang et al, 2010 (link)). After deparaffinization, antigen retrieval was done by autoclaving at 121°C for 10 min in 10 mM citrate buffer (pH 6.4). The affinity purified STAMP2 antibody (Proteintech Group, Inc.) was used at a dilution of 1:50 for 1 h at room temperature. The Supersensitive Detection kit (Biogenex) was used for antigen detection (Klokk et al, 2007 (link)).
For the neoadjuvant hormone therapy (NHT) and PSA recurrent samples, total of 194 prostate cancer specimens were obtained from Vancouver Prostate Centre Tissue Bank. The H&E slides were reviewed, and the desired areas were used to construct TMAs (Beecher Instruments, MD, USA). All specimens were from radical prostatectomies except 12 CRPC samples that were obtained through transurethral resection of prostate (TURP). Details of the material are presented in Supplementary Table S1. IHC was conducted by Ventana autostainer model Discover XT (Ventana Medical System, Tuscan, Arizona) with enzyme labeled biotin streptavidin system and solvent-resistant DAB Map kit.
+ Open protocol
+ Expand
9

Immunohistochemical Analysis of Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study was done on the total of 19 radical prostatectomy specimens obtained from Vancouver Prostate Centre Tissue Bank. The study protocol was approved by University of British Columbia (UBC) Clinical Research Ethics Board (CREB) and Vancouver Coast Hospital Research Institute Research (VCHRI) Research Ethics Board (REB). All patients gave informed consent as approved by UBC CREB and VCHRI REB. Immunohistochemical staining was conducted by Ventana autostainer model Discover XT™ (Ventana Medical System, Tuscan, Arizona) with enzyme‐labeled biotin–streptavidin system and solvent‐resistant DAB Map kit using 1/400 concentration of mouse monoclonal antibody against Cdc25C and 1/800 concentration of goat polyclonal antibody against CLU. All stained slides were digitalized with the SL801 autoloader and Leica SCN400 scanning system (Leica Microsystems, Concord, Ontario, Canada) at magnification equivalent to ×20 and subsequently stored in the SlidePath digital imaging hub (DIH; Leica Microsystems) of the Vancouver Prostate Centre. For each biomarker, representative cores (clearly positive, clearly negative, and mixed positive/negative) were manually identified by a pathologist and values on a four‐point scale were assigned.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!